16281-09-7 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
(5,6,7,8-TETRAHYDRO-NAPHTHALEN-1-YLOXY)-ACETIC ACID is used as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals for its ability to contribute to the development of new drug molecules and chemical compounds.
Used in Organic Chemistry:
(5,6,7,8-TETRAHYDRO-NAPHTHALEN-1-YLOXY)-ACETIC ACID is used as a building block in the production of various specialty chemicals for its role in creating complex molecular structures.
Used in Industrial Product Formulation:
(5,6,7,8-TETRAHYDRO-NAPHTHALEN-1-YLOXY)-ACETIC ACID is used as an antioxidant ingredient in the formulation of certain industrial products due to its strong antioxidant properties, which help protect against oxidative damage and degradation.
Check Digit Verification of cas no
The CAS Registry Mumber 16281-09-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,2,8 and 1 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 16281-09:
(7*1)+(6*6)+(5*2)+(4*8)+(3*1)+(2*0)+(1*9)=97
97 % 10 = 7
So 16281-09-7 is a valid CAS Registry Number.
16281-09-7Relevant academic research and scientific papers
Adams, Dave J.,Dietrich, Bart,Panja, Santanu,Qadir, Aleena,Trabold, Adriana,Zydel, Agata
, p. 7898 - 7901 (2021)
Mixing low molecular weight gelators (LMWGs) shows promise as a means of preparing innovative materials with exciting properties. Here, we investigate the effect of increasing hydrophobic chain length on the properties of the resulting multicomponent systems which are capable of showing ambidextrous phase behaviour on pH perturbation.
THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE
-
Page/Page column 46, (2008/12/07)
The present invention relates to substituted thiadiazole compounds of the formula (I) and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
